Skip to Content

Wuhan General Group (China) Inc

Rating as of

Company Profile

Business Description

Wuhan General Group (China) Inc is an alternative medicinal and botanicals company focused on the application of emerging technologies as well as the clinical research and health application of cannabidiol (CBD)-based medicine to the human and pet care industry for cancer, cardiovascular, mental disorders, chronic pain, and others in Canada, the United States, Europe, and Australia. It supplies medical grade CBD products, and superior patient care.

6500 Trans-Canada Highway, Suite 400
Montreal, QC, H9R 0A5
T +1 514 928-7368
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Dec 31, 2012
Fiscal Year End Dec 31, 2018
Stock Type Distressed
Employees 3